Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

94.91
-0.7598-0.79%
Post-market: 94.910.00000.00%19:30 EDT
Volume:19.86K
Turnover:1.88M
Market Cap:411.91M
PE:52.93
High:95.59
Open:95.59
Low:94.69
Close:95.67
52wk High:98.82
52wk Low:67.69
Shares:4.34M
Float Shares:4.34M
Volume Ratio:1.80
T/O Rate:0.46%
Dividend:1.55
Dividend Rate:1.63%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.67
PE(LYR):5.09

Loading ...

Eisai: Canada's Drug Agency Issues Final Positive Recommendation for Leqembi Reimbursement in Early Alzheimer's Disease

THOMSON REUTERS
·
Sep 01

Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says

MT Newswires Live
·
Aug 31

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-31

Reuters
·
Aug 31

Political and General News Events from August 31

Reuters
·
Aug 31

Zenas BioPharma Highlights FDA Review Acceptance for Obexelimab IgG4-RD Filing in Corporate Presentation

Reuters
·
Aug 31

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

TIPRANKS
·
Aug 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live
·
Aug 31

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 31

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

TIPRANKS
·
Aug 31

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS
·
Aug 31

Alnylam announces new data at ESC Congress on AMVUTTRA

TIPRANKS
·
Aug 31

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

TIPRANKS
·
Aug 29

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

TIPRANKS
·
Aug 29

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

TIPRANKS
·
Aug 29

Alnylam, Ionis Fall as Heart-Drug Data Raise Doubts over Combination Treatment

Reuters
·
Aug 28

Political and General News Events from August 28

Reuters
·
Aug 28

Biogen CEO Viehbacher to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Aug 28

Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets

TIPRANKS
·
Aug 28